Suppr超能文献

用于纯化特定维生素K依赖性蛋白质的改进程序。

Improved procedures for the purification of selected vitamin K-dependent proteins.

作者信息

Novoa E, Seegers W H, Hassouna H I

出版信息

Prep Biochem. 1976;6(5):307-38. doi: 10.1080/00327487608061622.

Abstract

Improved methods are described to obtain bovine prothrombin, Factor IX, Protein C, and autoprothrombin III (Factor X, Auto-III) in purified form. The prothrombin had a specific activity of 4,340 Iowa units/mg. Theoretically, a preparation of clean thrombin should have a specific activity of 8,200 U/mg, because 47.08% of the protein in prothrombin is lost when thrombin forms. Such thrombin preparations have been obtained (Arch. Biochem. Biophys. 121, 372 (1967)). The prothrombin concentration of bovine plasma is near 60 mg/liter. Protein C, first isolated by Stenflo (J. Biol. Chem. 251, 355 (1976)), was found to be the precursor of autoprothrombin II-A (Auto-II-A), discovered earlier (Thromb. Diath. Haemorrh. 5, 218 (1960)). Protein C (Factor XIV) was converted to Auto-II-A (Factor XIVa) by thrombin. Digesting purified Auto-III with purified thrombin removed a small glycopeptide from the COOH-terminal end of the heavy chain to yield Auto-IIIm. Auto-III thrombin leads to Auto-IIIm + peptide. Auto-IIIm was not converted to the active enzyme with thromboplastin, and furthermore, inhibited the activation of purified native Auto-III with thromboplastin. Auto-IIIm was also not converted to the active enzymes when the procoagulants consisted of purified Factor VIII, purified Factor IXa, platelet factor 3 and calcium ions. The "activation peptide" released by RVV-X from the NH2-terminal end of the heavy chain and the active enzyme (Auto-Cm) were purified. Auto-III was also activated with purified RVV-X. The same "actid of Auto-Cm. Purified Factor IX developed anticoagulant activity when reacted with an optimum concentration of purified thrombin. A suitable reagent for the assay of Factor IX was prepared by removing prothrombin complex from anticoagulated bovine plasma and restoring the prothrombin and Auto-III concentration with use of the respective purified proenzymes.

摘要

本文描述了获得纯化形式的牛凝血酶原、因子IX、蛋白C和自身凝血酶原III(因子X、自身III)的改进方法。该凝血酶原的比活性为4340艾奥瓦单位/毫克。理论上,纯凝血酶制剂的比活性应为8200 U/毫克,因为凝血酶形成时,凝血酶原中47.08%的蛋白质会损失。已经获得了这样的凝血酶制剂(《生物化学与生物物理学文献》121, 372 (1967))。牛血浆中凝血酶原浓度接近60毫克/升。蛋白C最早由斯滕弗洛分离得到(《生物化学杂志》251, 355 (1976)),被发现是更早发现的自身凝血酶原II - A(自身II - A)的前体(《血栓与止血学》5, 218 (1960))。蛋白C(因子XIV)被凝血酶转化为自身II - A(因子XIVa)。用纯化的凝血酶消化纯化的自身III,从重链的COOH末端去除一个小糖肽,产生自身IIIm。自身III凝血酶导致自身IIIm + 肽。自身IIIm不能被凝血活酶转化为活性酶,此外,还抑制纯化的天然自身III被凝血活酶激活。当促凝剂由纯化的因子VIII、纯化的因子IXa、血小板因子3和钙离子组成时,自身IIIm也不能转化为活性酶。从重链的NH2末端由RVV - X释放的“激活肽”和活性酶(自身Cm)被纯化。自身III也用纯化的RVV - X激活。自身Cm具有相同的“活性”。纯化的因子IX与最佳浓度的纯化凝血酶反应时产生抗凝活性。通过从抗凝牛血浆中去除凝血酶原复合物,并使用各自纯化的酶原恢复凝血酶原和自身III浓度,制备了一种用于检测因子IX的合适试剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验